NeuroPace Inc
NPCEFigures shown here come from public SEC filings. Dates beside each section show the available history.
How NeuroPace Inc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 4 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 25, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Engineers Gate Manager LP | 2026-03-31 | 21,140 | $278K | SEC filing |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2026-03-31 | 17,308 | Not shown | SEC filing |
| Informed Momentum Co LLC | 2026-03-31 | 41,289 | $543K | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 2,566,839 | $33.8M | SEC filing |
| UBS Group AG | 2026-03-31 | 27,803 | $366K | SEC filing |
| SBI Securities Co., Ltd. | 2026-03-31 | 170 | $2.24K | SEC filing |
| Root Financial Partners, LLC | 2026-03-31 | 33 | $434 | SEC filing |
| Optiver Holding B.V. | 2026-03-31 | 254 | $3.34K | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 618,119 | $8.13M | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 1,019 | $13.4K | SEC filing |
| Larson Financial Group LLC | 2026-03-31 | 27 | $355 | SEC filing |
| Activest Wealth Management | 2026-03-31 | 125 | $1.64K | SEC filing |
| ARMISTICE CAPITAL, LLC | 2026-03-31 | 692,000 | $9.1M | SEC filing |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 2026-03-31 | 360,065 | $4.73M | SEC filing |
| Bank of New York Mellon Corp | 2026-03-31 | 52,260 | $687K | SEC filing |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 2026-03-31 | 217,738 | $2.86M | SEC filing |
| Man Group plc | 2026-03-31 | 43,897 | $577K | SEC filing |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2026-03-31 | 1,378 | $18.1K | SEC filing |
| Soleus Capital Management, L.P. | 2026-03-31 | 2,932,207 | $38.6M | SEC filing |
| Sound Income Strategies, LLC | 2026-03-31 | 21 | $295 | SEC filing |
- Each value is checked against NeuroPace Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at NeuroPace Inc's share price.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Russell Investments Group, Ltd.: 73,692 shares reported 2025-12-31; 179,021 shares reported 2026-03-31.
- Palumbo Wealth Management LLC: 214,175 shares reported 2025-12-31; 210,469 shares reported 2026-03-31.
- Legal & General Group Plc: 2,602 shares reported 2025-12-31; 2,190 shares reported 2026-03-31.
- TUDOR INVESTMENT CORP ET AL: 193,346 shares reported 2025-12-31; 135,705 shares reported 2026-03-31.
- ALGERT GLOBAL LLC: 172,926 shares reported 2025-12-31; 179,556 shares reported 2026-03-31.
- CANADA PENSION PLAN INVESTMENT BOARD: 20,200 shares reported 2025-12-31; 27,800 shares reported 2026-03-31.
- Soleus Capital Management, L.P.: 2,703,208 shares reported 2025-12-31; 2,932,207 shares reported 2026-03-31.
- Tower Research Capital LLC (TRC): 2,515 shares reported 2025-12-31; 1,019 shares reported 2026-03-31.
- SBI Securities Co., Ltd.: 20 shares reported 2025-12-31; 170 shares reported 2026-03-31.
- Engineers Gate Manager LP: 12,150 shares reported 2025-12-31; 21,140 shares reported 2026-03-31.
100 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among NeuroPace Inc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-12-15 · Morrell Martha: Larger than 55 of the 61 other insider sales of Common Stock on file. SEC filing
- 2025-05-14 · ORBIMED ADVISORS LLC: Larger than 58 of the 61 other insider sales of Common Stock on file. SEC filing
- 2025-05-14 · ORBIMED ADVISORS LLC: Larger than 56 of the 61 other insider sales of Common Stock on file. SEC filing
- 2025-02-21 · Morrell Martha: Larger than 57 of the 61 other insider sales of Common Stock on file. SEC filing
- 2025-02-20 · KCK LTD.: Larger than all 61 other insider sales of Common Stock on file. SEC filing
- 2024-10-25 · KCK LTD.: Larger than 59 of the 61 other insider sales of Common Stock on file. SEC filing
- 2024-04-11 · ORBIMED ADVISORS LLC: Larger than 60 of the 61 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-15 | Morrell Martha · CHIEF MEDICAL OFFICER | Common Stock | S — Open market or private sale | −25,000 | 15.97 | SEC filing |
| 2025-05-14 | ORBIMED ADVISORS LLC · 10% owner | Common Stock | S — Open market or private sale | −34,000 | 15.94 | SEC filing |
| 2025-05-14 | ORBIMED ADVISORS LLC · 10% owner | Common Stock | S — Open market or private sale | −134,136 | 15.83 | SEC filing |
| 2025-02-21 | Morrell Martha · CHIEF MEDICAL OFFICER | Common Stock | S — Open market or private sale | −78,334 | 13.72 | SEC filing |
| 2025-02-20 | KCK LTD. · 10% owner | Common Stock | S — Open market or private sale | −5,270,845 | 9.40 | SEC filing |
| 2025-01-30 | Morrell Martha · CHIEF MEDICAL OFFICER | Common Stock | S — Open market or private sale | −200 | 15.00 | SEC filing |
| 2025-01-29 | Morrell Martha · CHIEF MEDICAL OFFICER | Common Stock | S — Open market or private sale | −100 | 15.00 | SEC filing |
| 2025-01-24 | Morrell Martha · CHIEF MEDICAL OFFICER | Common Stock | S — Open market or private sale | −3,200 | 15.01 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-24 | Morrell Martha · CHIEF MEDICAL OFFICER | Common Stock | F — Payment of exercise price or tax by delivering securities | −335 | SEC filing |
| 2026-06-19 | Kumar Rakhi · Director | Common Stock | A — Grant, award, or other acquisition | +989 | SEC filing |
| 2026-06-19 | Fischer Frank M · Director | Common Stock | A — Grant, award, or other acquisition | +1,467 | SEC filing |
| 2026-06-19 | Geiger Uri · Director | Common Stock | A — Grant, award, or other acquisition | +789 | SEC filing |
| 2026-06-05 | Kumar Rakhi · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +5,368 | SEC filing |
| 2026-06-05 | Geiger Uri · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +5,368 | SEC filing |
| 2026-06-05 | Huennekens R Scott · Director | Common Stock | A — Grant, award, or other acquisition | +2,890 | SEC filing |
| 2026-06-05 | Huennekens R Scott · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +5,368 | SEC filing |
Showing 8 of 29 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.